New HIV/AIDS Findings from Mexican Social Security Institute Described (Incidence of Non-alcoholic Fatty Liver Disease In Antiretroviral Therapy-naive People With Human Immunodeficiency Virus Who Start Dtg/abc/3tc Compared To Bic/ftc/taf At...).

MLA

“New HIV/AIDS Findings from Mexican Social Security Institute Described (Incidence of Non-Alcoholic Fatty Liver Disease In Antiretroviral Therapy-Naive People With Human Immunodeficiency Virus Who Start Dtg/Abc/3tc Compared To Bic/Ftc/Taf At...).” Gastroenterology Week, Oct. 2024, p. 1369. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180470189&authtype=sso&custid=ns315887.

APA

New HIV/AIDS Findings from Mexican Social Security Institute Described (Incidence of Non-alcoholic Fatty Liver Disease In Antiretroviral Therapy-naive People With Human Immunodeficiency Virus Who Start Dtg/abc/3tc Compared To Bic/ftc/taf At...). (2024). Gastroenterology Week, 1369.

Chicago

“New HIV/AIDS Findings from Mexican Social Security Institute Described (Incidence of Non-Alcoholic Fatty Liver Disease In Antiretroviral Therapy-Naive People With Human Immunodeficiency Virus Who Start Dtg/Abc/3tc Compared To Bic/Ftc/Taf At...).” 2024. Gastroenterology Week, October, 1369. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180470189&authtype=sso&custid=ns315887.